m+Medelevator.RU
← Поиск публикаций
Nature communications · 2026

Pregnancy promotes tumor metastasis through adenosine-induced immunosuppressive neutrophils in pre-metastatic microenvironment.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Chen Chen, Shi Jiahong, Lei Yutiantian, Wang Qian, Cao Peihai, Hou Dairu, Huang Mengdi, Wang Ruiying, Mu Qiuyu, Lv Tingting, Jia Rui, Si Mingjun, Jiang Dingge, Li Lei, Cai Zhixuan, Huang Yakun, Sun Jiahao, Jiao Lianying, Xiao Zhengtao, Li Yuhan, Wang Binxian, Huang Shan, Du Wenqian, Bai Lu, Ma Jinlu, Han Suxia, Zhang Baojun, Lin Chen, Guo Hui, Meng Xiangjiao, Hou Yuzhu

Аннотация

Tumor metastasis is the primary cause of cancer treatment failure and mortality. Pregnant patients with cancer sometimes experience a poor prognosis and accelerated disease progression, yet the underlying mechanisms remain poorly understood. Here we show that pregnancy enhances tumor metastasis in female mice by elevating adenosine levels, which drives pre-metastatic niche remodeling. Myeloid cells in placental and uterine tissues exhibit increased expression of adenosine-generating enzymes, CD39 and CD73. The accumulated adenosine recruits neutrophils into the tissues of the pre-metastatic microenvironment and upregulates PD-L1 expression on these cells through the cAMP-PKA-NF-κB pathway, thereby suppressing CD8+ T cell function. Consistent with murine models, pregnant women exhibit elevated adenosine levels and increased PD-L1+ neutrophils in peripheral blood, hindering human T cell activation. Inhibiting the adenosine-PD-L1+ neutrophil axis reverses, at least partially, pregnancy-accelerated metastasis without affecting fetal development. These findings shed light on the mechanism of tumor metastasis mice during pregnancy and suggest potential therapeutic targets for treating cancers in pregnant patients.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты